TY - JOUR
T1 - Pharmacologic treatment of hyperthyroidism during lactation
AU - Glatstein, Miguel Marcelo
AU - Garcia-Bournissen, Facundo
AU - Giglio, Norberto
AU - Finkelstein, Yaron
AU - Koren, Gideon
PY - 2009
Y1 - 2009
N2 - QUESTION: I have a patient who has hyperthyroidism due to Graves disease. She was taking methimazole but discontinued when she found out she was pregnant. She is currently close to delivery and might require antithyroid therapy in the postpartum period. Can methimazole cross into human milk, and is breastfeeding safe for her infant? ANSWER: The exposure of infants to methimazole or propylthiouracil through breast milk is minimal and not clinically significant. Women with hyperthyroidism using methimazole or propylthiouracil should not be discouraged from breastfeeding, as the benefits of breastfeeding largely outweigh the theoretical minimal risks.
AB - QUESTION: I have a patient who has hyperthyroidism due to Graves disease. She was taking methimazole but discontinued when she found out she was pregnant. She is currently close to delivery and might require antithyroid therapy in the postpartum period. Can methimazole cross into human milk, and is breastfeeding safe for her infant? ANSWER: The exposure of infants to methimazole or propylthiouracil through breast milk is minimal and not clinically significant. Women with hyperthyroidism using methimazole or propylthiouracil should not be discouraged from breastfeeding, as the benefits of breastfeeding largely outweigh the theoretical minimal risks.
UR - http://www.scopus.com/inward/record.url?scp=70349264532&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 19675263
AN - SCOPUS:70349264532
SN - 0008-350X
VL - 55
SP - 797
EP - 798
JO - Canadian Family Physician
JF - Canadian Family Physician
IS - 8
ER -